Kai-Hsin Lin
Overview
Explore the profile of Kai-Hsin Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng C, Lu M, Chang H, Yang Y, Wu C, Lin D, et al.
Ann Hematol
. 2025 Feb;
104(1):753-760.
PMID: 39903278
Graft-versus-host disease (GVHD) is a major concern for patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Ruxolitinib has been proven effective in treating adult steroid-refractory GVHD; however, studies on pediatric...
2.
Chang Y, Yu C, Lu M, Jou S, Lin C, Lin K, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(9):e31176.
PMID: 38967585
Introduction: Neuroblastoma is a pediatric malignancy with heterogeneous clinical outcomes. Our aim was to identify prognostic genetic markers for patients with neuroblastoma, who were treated with the Taiwan Pediatric Oncology...
3.
Yu C, Su Y, Jou S, Lu M, Lin C, Lin K, et al.
Pathol Res Pract
. 2024 Apr;
256:155287.
PMID: 38579576
The lack of expression of terminal deoxynucleotidyl transferase (TdT) is frequently associated with KMT2A-rearranged subtype of pediatric acute lymphoblastic leukemia (ALL). However, this association has not been investigated extensively in...
4.
Yu C, Chang Y, Wang D, Jou S, Lin C, Lin K, et al.
Sci Rep
. 2023 Jan;
13(1):490.
PMID: 36627439
Mercaptopurine intolerance is an adverse effect of mercaptopurine administration in pediatric patients with acute lymphoblastic leukemia (ALL). NUDT15 variants have emerged as major determinants of mercaptopurine intolerance, especially in the...
5.
Yu C, Jou S, Su Y, Coustan-Smith E, Wu G, Cheng C, et al.
Cancer
. 2022 Dec;
129(5):790-802.
PMID: 36537587
Background: This study analyzed data from two consecutive protocols for children newly diagnosed with acute lymphoblastic leukemia (ALL) to determine the clinical impact of minimal/measurable residual disease (MRD) and recently...
6.
Chang Y, Jou S, Yen C, Lin C, Yu C, Chang S, et al.
Am J Cancer Res
. 2022 Nov;
12(10):4764-4774.
PMID: 36381326
MicroRNA (miRNA) expression is reportedly associated with clinical outcomes in childhood acute lymphoblastic leukemia (ALL). Here, we aimed at investigating whether miRNA expression is associated with clinical outcomes in pediatric...
7.
Chou S, Su Y, Lu M, Chang H, Yang Y, Lin D, et al.
Pediatr Blood Cancer
. 2022 Oct;
70(1):e29990.
PMID: 36250996
Background: Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. Minimal residual disease (MRD) detection is the most powerful prognostic tool for monitoring treatment efficacy and predicting clinical outcomes....
8.
Huang T, Hung G, Weng T, Wang F, Lee C, Lin D, et al.
Cancer
. 2022 Oct;
128(23):4139-4149.
PMID: 36223226
Background: Primary malignant mediastinal germ cell tumors (GCTs) are rare pediatric tumors that have a poorer prognosis compared to GCTs occurring elsewhere in the body. The current study aimed to...
9.
Yu C, Wu G, Chang C, Jou S, Lu M, Lin K, et al.
J Mol Diagn
. 2022 Aug;
24(11):1195-1206.
PMID: 35963521
Identification of specific leukemia subtypes is a key to successful risk-directed therapy in childhood acute lymphoblastic leukemia (ALL). Although RNA sequencing (RNA-seq) is the best approach to identify virtually all...
10.
Lin N, Chen S, Chang H, Lu M, Yang Y, Chou S, et al.
Oncogenesis
. 2022 Feb;
11(1):8.
PMID: 35169131
Neuroblastoma (NB) is a childhood tumor derived from the sympathoadrenal lineage of the neural crest progenitor cells. Core 1 β1,3-galactosyltransferase (C1GALT1) controls the crucial step of GalNAc-type O-glycosylation, and its...